Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Sale | -$10.8M | -48.1K | -0.81% | $224.33 | 5.91M | Nov 22, 2021 | Direct | F1, F2 |
transaction | MEDP | Common Stock | Sale | -$5.54M | -26.1K | -0.44% | $212.64 | 5.88M | Nov 23, 2021 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. |
F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $219.65 to $229.19. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $221.11. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |